A new review describes how conduction system pacing, led by left bundle branch area pacing, is replacing conventional right ...

Background Up to 30% of patients with hypertrophic cardiomyopathy have the myocardial bridge (MB) mainly in the left anterior ...

Cardiac arrhythmias are a leading cause of morbidity and mortality worldwide. Catheter ablation provides a minimally invasive means to target and eliminate arrhythmogenic substrates within the heart.

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation.

CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...

For ventricular tachycardia (VT), catheter ablation is often seen as an option of last resort, however, some are questioning whether there has been too much emphasis on antiarrhythmic medication. In ...

A new, multicenter study demonstrated that ablation treatment may be a better first option than medication for many heart attack survivors who develop abnormal electrical short circuits in their heart ...

SAN FRANCISCO -- Noninvasive stereotactic radiotherapy (RT) for refractory ventricular tachycardia (VT) achieved outcomes similar to catheter ablation with substantially fewer serious adverse events ...

Following catheter ablation for AF, implantation of a device that occludes the left atrial appendage obviates the need for oral anticoagulation after 3 months, reduces the risk of non-major bleeding ...